Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 6/20 | 0.61 |
| ▸ | CA2 | P00918 | 6/20 | 0.61 |
| ▸ | CA9 | Q16790 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | CTRC | Q99895 | 1/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.53 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.53 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | GFER | P55789 | 1/20 | 0.53 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.52 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL133729 | 1.00 | CA12 (0.61) | CA12CA2CA9KDM4ESIRT2 | |
| SCHEMBL30251630 | 1.00 | CA12 (0.61) | CA12CA2CA9KDM4ESIRT2 | |
| SCHEMBL135614 | 1.00 | CA12 (0.61) | CA12CA2CA9KDM4ESIRT2 | |
| SCHEMBL8507493 | 0.98 | CA12 (0.59) | CA12CA2CA9KDM4ESIRT2 | |
| SCHEMBL11593458 | 0.98 | CA12 (0.59) | CA12CA2CA9KDM4ESIRT2 | |
| SCHEMBL294855 | 0.98 | CA12 (0.59) | CA12CA2CA9KDM4ESIRT2 | |
| SCHEMBL11420073 | 0.98 | CA12 (0.59) | CA12CA2CA9KDM4ESIRT2 | |
| SCHEMBL11420096 | 0.98 | CA12 (0.59) | CA12CA2CA9KDM4ESIRT2 | |
| SCHEMBL11337077 | 0.98 | CA12 (0.59) | CA12CA2CA9KDM4ESIRT2 | |
| SCHEMBL10875534 | 0.98 | CA12 (0.59) | CA12CA2CA9KDM4ESIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 903 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118949864-B | Straw fiber aerogel for uranium adsorption and preparation method thereof | 海南大学 | 2025-02-14 | — | — | CN | claimed |
| WO-2024255129-A1 | RECYCLABLE EPOXY RESIN, SYSTEM MATERIAL AND COMPOSITE MATERIAL THEREOF, AND RECOVERY METHODS THEREFOR | 道生天合材料科技(上海)股份有限公司 | 2024-12-19 | — | — | WO | claimed |
| CN-118949864-A | Straw fiber aerogel for uranium adsorption and preparation method thereof | 海南大学 | 2024-11-15 | — | — | CN | claimed |
| CN-116393256-A | High-mud high-oxidation-rate low-grade zinc oxide ore flotation agent and application thereof | 西北矿冶研究院 | 2023-07-07 | — | — | CN | claimed |
| CN-114057304-B | Composition for phosphorus-free pre-filming, method for pre-filming circulating cooling water system by using composition and application | 中国石油化工股份有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-114057304-A | Composition for phosphorus-free pre-filming, method for pre-filming circulating cooling water system by using composition and application | 中国石油化工股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| WO-2021117053-A1 | AN IMPROVED PROCESS FOR PREPARATION OF PURE ALDOXIME | DR. SILVIU PHARMACHEM PVT. LTD. (IN) | 2021-06-17 | — | — | WO | claimed |
| CN-110714213-A | Cyanide-free alkaline cuprous copper electroplating complexing agent | 武汉奥邦表面技术有限公司 | 2020-01-21 | — | — | CN | claimed |
| CN-106238217-A | A kind of preparation method of zinc oxide ore collecting agent | 江西理工大学 | 2016-12-21 | — | — | CN | claimed |
| CN-106198508-A | A kind of high sensitivity quickly detects the method containing heavy metal class pesticide | 中国科学院大连化学物理研究所 | 2016-12-07 | — | — | CN | claimed |
| US-20020123645-A1 | Method for producing optically active chrysanthemic acid | SUMITOMO CHEMICAL COMPANY, LIMITED | 2002-09-05 | — | — | US | claimed |
| EP-1236708-A1 | Method for producing optically active chrysanthemic acid | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-09-04 | — | — | EP | claimed |
| US-6268525-B1 | REACTING CHRYSANTHEMIC ACID HAVING TRANS ISOMER WITH OPTICALLY ACTIVE AMINE TO OPTICALLY RESOLVE CHRYSANTHEMIC ACID | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-07-31 | — | — | US | claimed |
| EP-0933349-A1 | Method for producing optically active chrysanthemic acid | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-08-04 | — | — | EP | claimed |
| WO-1998005630-A1 | PROCESS FOR THE PREPARATION OF ORGANIC NITRILES | ALLIEDSIGNAL INC. (US) | 1998-02-12 | — | — | WO | claimed |
| EP-0310059-B1 | Optical information recording medium | FUJI PHOTO FILM CO LTD (JP) | 1995-09-13 | — | — | EP | claimed |
| US-5182186-A | Compact disks, methine dyes, quenchers | FUJI PHOTO FILM CO., LTD. (JP) | 1993-01-26 | — | — | US | claimed |
| US-4885228-A | ONE LAYER CONTAINING A CYANINE DYE; HEAT, MOISTURE AND LIGHT RESISTANCE; LASER BEAM READING | FUJI PHOTO FILM CO., LTD. (JP) | 1989-12-05 | — | — | US | claimed |
| US-4851322-A | CYCLOHEPTA/B/PYRROLE DYES | FUJI PHOTO FILM CO., LTD. (JP) | 1989-07-25 | — | — | US | claimed |
| EP-0310059-A2 | Optical information recording medium | FUJI PHOTO FILM CO., LTD. (JP) | 1989-04-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020123645-A1 | Method for producing optically active chrysanthemic acid | ENO1, CYP8B1, CRYAA | CA12 254/4885CA2 433/4885CA9 81/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.